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Abstract
Mild anemia and leukopenia are the most common hematologic problems of acute
brucellosis. Mild thrombocytopenia also occurs, but severe cases are uncommon.
Thrombocytopenia occurs because of bone marrow suppression, hypersplenisem,
hemophagocytosis, and immunologic destruction of the cells or disseminated
intravascular coagulation. In endemic areas, hemorrhagic fevers, hematologic
malignancies, as well as idiopathic thrombocytopenic purpura should be considered
as differential diagnoses for complicated brucellosis. Thrombocytopenia and bleeding
can be improved with antibiotic and hematologic supportive therapy whereas in
severe cases corticosteroid therapy or splenectomy might be necessary.
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1. Introduction
Although brucellosis is a treatable and non-severe disease, 5–10% of patients experience some
complications [1]. Brucella plays an important role in infectious diseases, and can mimic many
other infectious and non-infectious diseases. This mimicry can result in delayed diagnosis and
increased mortality and morbidity. Almost all body systems can be affected by brucellosis,
including the hematological system.
The most common hematological finding in brucellosis is an unchanged hemogram, including
normal counts of platelets, white blood cells, and hemoglobin [2]. Hematological problems
may occur and are most common in children with brucella infection, but sometimes occur in
adults as well. Several blood disorders have been reported in brucellosis, including hemolytic
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anemia [3], thrombocytopenia, leukopenia [4], leukocytosis [5], thrombocytosis [6], and
pancytopenia [7]. Mild anemia and leukopenia are the most common complications of acute
infection. Mild thrombocytopenia also occurs in about 1–26% of the patients, while severe cases
are uncommon [4].
Isolated thrombocytopenia or pancytopenia has been rarely reported. Severe thrombocytope‐
nia with pancytopenia imitates hematologic diseases (Figure 1). Thrombocytopenia occurs less
than leukopenia in brucellosis. We and others have several published [8–10] and unpublished
papers regarding confirmed brucellosis cases presenting with severe hemorrhagic fever
mimicking Crimean-Congo Hemorrhagic Fever (CCHF). These patients are usually isolated
before an established diagnosis is reached.
Mild thrombocytopenia is more common than the severe form and the incidence of spleno‐
megaly in thrombocytopenic cases is higher than that reported for uncomplicated brucellosis
[11]. Thrombocytopenic purpura and microangiopathy may also occur in brucellosis [12, 13].
The latter event may be associated with thrombocytopenia, bleeding, hemolytic anemia, and
impaired consciousness. Disseminated intravascular coagulation (DIC) is rarely seen [14]. DIC
may occur in the patients suffering from gram-negative sepsis. Bacterial endotoxins activate
the coagulation cascade. Microrhrombi are deposited in the wall of the vasculature, resulting
in thrombiosis, bleeding, and Microangiopatic Hemolytic Anemia (MAHA). DIC and/or
MAHA are rarely reported in association with brucellar endocarditis with the clinical presen‐
tation of mild disease to severe bleeding, thrombosis, and death [2].
Hence, brucellosis must be considered in the differential diagnosis of all those conditions leading
to diverse hematologic  disorders including pancytopenia,  hemolytic  anemia,  leukopenia,
thrombocytopenia, and disseminated intravascular coagulation in endemic areas [15, 16].
Figure 1. Ecchymosis of the lower limbs in a patient with brucella-induced hemophagocytosis.
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The key point in the evaluation of thrombocytopenia is to prepare a peripheral blood smear
to assess the morphology of the blood cells and to exclude pseudo-thrombocytopenia,
especially in patients with an unexplained low platelet count. The latter condition is attributed
to the use of certain anti-coagulants (such as ethylenediamine tetra-acetic) and subsequent
platelet agglutination [17].
Although bone marrow smear and culture plays an important role in detecting infectious
causes of thrombocytopenia, it is possible to find the etiology of thrombocytopenia with less
invasive procedures such as blood smear and culture. In many cases, thrombocytopenia will
disappear after antibiotic therapy within a few days. Therefore, in suspected infectious
induced thrombocytopenia, there is often no need for bone marrow examination for confirmed
diagnosis. It is a well-known fact that thrombocytosis may be a marker of inflammation, but
low platelet count can be a significant alarming sign for severe infection and infection-induced
immunosuppression [18]. Microbial endotoxin can cause endothelial damage, platelet
adhesion and/or its removal from the bloodstream [19].
Thrombocytopenia may occur due to platelet destruction by the immune system. A positive
Coombs test in most patients with brucella, response to corticosteroid, and detection of anti-
platelet antibodies are the evidence of such mechanism [20].
In general, low platelet count may be due to the production failure in the bone marrow, being
trapped in an enlarged spleen, or damaged in the peripheral circulation. Thrombocytopenia
due to infectious diseases occurs because of bone marrow suppression, hypersplenism,
hemophagocytosis, immunologic destruction of the cells, and DIC [21, 10].
Granuloma formation in the bone marrow is added to the etiologies of thrombocytopenia in
brucellosis [22]. In one study [23], bone marrow biopsy revealed hypercellular marrow in 75%
and granuloma formation in 41% of the samples. Seventy-five percent of the patients with both
thrombocytopenia and hypercellular marrow had splenomegaly, as well. In hemophagocyto‐
sis phenomena, active histiocytes play an important role in erythrophagocytosis, leukopha‐
gocytosis, and platelet phagocytosis. Hemophagocytosis occurs not only during the course of
brucellosis, but also in many infectious and noninfectious diseases including viral, fungal,
bacterial, parasitic, malignant, and reumatological diseases [24].
Despite the existence of thrombocytopenia, the bone marrow may be hypercellular with
sufficient megakaryocytes or hypocellular [25, 23]. Therefore, bone marrow suppression is not
a good explanation for thrombocytopenia. Hence, other etiologies should be considered for
this cytopenia. One of the significant causes of thrombocytopenia is stimulated autoimmune
phenomena induced by brucella bacteria that may lead to bleeding, purpura, and hemolytic
anemia [26]. Moreover, monoclonal hypergammaglobulinemia and cryoglobulinemia are rare
complications of brucellosis [27].
Hemorrhagic fevers in endemic areas, hematologic malignancies, as well as idiopathic
thrombocytopenic purpura (ITP) should be considered as the differential diagnosis of brucel‐
losis, even if the patient is afebrile at the time of admission [28]. Brucellosis and CCHF are both
common in rural areas of endemic regions. They affect farmers and shepherds. Both of these
diseases cause fever, rigors, thrombocytopenia, and bleeding, sometimes without other signs
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and symptoms. However, the main difference is a significant reduction in incidence of
Crimean-Congo in the winter due to inactivity of the carrier ticks [29] while brucellosis
continues to occur. Severe thrombocytopenia and/or hemorrhage are characteristic clinical
features of severe CCHF but they rarely occur in brucellosis. Finally, serologic tests, viral
polymerase chain reaction, and obvious contact of CCHF patients with blood and tissues of
sick animals or other affected patients, as well as history of tick bite will confirm the diagnosis
of CCHF.
In case of brucella induced thrombocytopenia, severe thrombocytopenia and bleeding of the
urinary tract, skin, gastrointestinal tract, as well as hemoptysis and hematemesis rarely occur
[30]. As mentioned above, hematological changes are mild and subside with anti-brucella
treatment, but even severe bleeding can be improved with antibiotic and hematologic
supportive therapy [31]. In emergent cases with severe thrombocytopenia and bleeding, a short
trial of intravenous immunoglobulin (IVIG) has been recommended to increase platelet count
and to control bleeding. In the patients with platelets count of less than 10.000 mm3, cortico‐
steroid therapy would be effective [4, 32]. However, in rare cases of severe and refractory
thrombocytopenia, splenectomy may be helpful [33]. In one study [34], among 19 patients with
severe thrombocytopenia, 10 received corticosteroids for less than two months and responded
well to the treatment. Seven patients received corticosteroid for more than two months, 4 of
them recovered and 3 underwent splenectomy and finally recovered. Two out of 19 patients
died.
2. Summary
Brucella induced severe thrombocytopenia and pancytopenia imitates several hematological
diseases. Not only infectious disease specialists, but also other experts in other fields such as
gynecology, gastroenterology, hematology, ENT, dermatology, and urology should be
familiar with brucellosis and its uncommon clinical pictures including bleeding and throm‐
bocytopenia. All physicians should be aware of infectious diseases such as brucellosis and
CCHF, which may be presented with severe thrombocytopenia and have to include them in
the differential diagnosis of any disorder with thrombocytopenia and bleeding, even in afebrile
patients. In these conditions, the patient's occupation and/or a minor fever may provide
important clues to the diagnosis of infectious diseases such as brucellosis.
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